Corcept Therapeutics

YTD

ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.

CEO

Joseph K. Belanoff

CEOJoseph K. Belanoff

Employees

730

Employees730

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

1998

Founded1998

Employees

730

Employees730

CORT Key Statistics

Market cap

8.77B

Market cap8.77B

Price-Earnings ratio

239.17

Price-Earnings ratio239.17

Dividend yield

—

Dividend yield—

Average volume

953.23K

Average volume953.23K

High today

$85.40

High today$85.40

Low today

$81.45

Low today$81.45

Open price

$84.30

Open price$84.30

Volume

850.17K

Volume850.17K

52 Week high

$91.00

52 Week high$91.00

52 Week low

$28.66

52 Week low$28.66

Stock Snapshot

Corcept Therapeutics(CORT) stock is priced at $82.00, giving the company a market capitalization of 8.77B. It carries a P/E multiple of 239.17.

On 2026-06-18, Corcept Therapeutics(CORT) stock moved within a range of $81.45 to $85.40. With shares now at $82.00, the stock is trading +0.7% above its intraday low and -4.0% below the session's peak.

Trading volume for Corcept Therapeutics(CORT) stock has reached 850.17K, versus its average volume of 953.23K.

The stock's 52-week range extends from a low of $28.66 to a high of $91.00.

CORT News

Simply Wall St 10h

Corcept Therapeutics Stock After 114% YTD Surge Is The Rally Justified

If you are wondering whether Corcept Therapeutics stock is still attractively priced after a strong run, the key question now is how its current share price com...

TipRanks 11h

Corcept Resubmits FDA Application for Relacorilant in Cushing’s

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

TipRanks 12h

Corcept Therapeutics resubmits NDA for Relacorilant in Cushing’s Syndrome

The company states: “Corcept Therapeutics (CORT) announced it has resubmitted its New Drug Application to the U.S. Food and Drug Administration for relacorilant...

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

More CORT News

CNN 6d

symbol__ Stock Quote Price and Forecast - CNN

...

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Novo Nordisk

Broadcom

Palantir Technologies

Robinhood Markets

Gilead Sciences

Spotify

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.